The role of FasR/FasL system in pathogenesis of myeloprolyferative neoplasms
Myeloproliferative neoplasms (MPN) are hematological malignancies characterized by uncontrolled cell proliferation and impaired apoptosis. The FasR/FasL system is involved in the control of apoptosis in different cell types. Here we have investigated the role of FasR/FasL in the pathogenesis of MPNs...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Belgrade, University of Novi Sad
2010-01-01
|
Series: | Archives of Biological Sciences |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0354-4664/2010/0354-46641002223S.pdf |
id |
doaj-69d5626d6ea44068ba6e07345d96fcbe |
---|---|
record_format |
Article |
spelling |
doaj-69d5626d6ea44068ba6e07345d96fcbe2020-11-24T23:02:12ZengUniversity of Belgrade, University of Novi SadArchives of Biological Sciences0354-46642010-01-0162222323010.2298/ABS1002223SThe role of FasR/FasL system in pathogenesis of myeloprolyferative neoplasmsSpasovski VesnaTosić NatasaKostić TatjanaZukić BrankaStojiljković MajaČolović MilicaPavlović SonjaMyeloproliferative neoplasms (MPN) are hematological malignancies characterized by uncontrolled cell proliferation and impaired apoptosis. The FasR/FasL system is involved in the control of apoptosis in different cell types. Here we have investigated the role of FasR/FasL in the pathogenesis of MPNs. We compared FasR/FasL expression between MPN patients (24) and healthy individuals using the real-time PCR assay. We found an increase of FasR expression in MPN patients. No difference was detected in FasL expression. Mutation V617F in the JAK2 gene, a hallmark of MPN, was detected in 13/24 patients. We found that neither FasR nor FasL expression were related to the presence of JAK2 V617F mutation. http://www.doiserbia.nb.rs/img/doi/0354-4664/2010/0354-46641002223S.pdfMyeloproliferative neoplasmsFasR/FasLJAK2 V617F mutation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Spasovski Vesna Tosić Natasa Kostić Tatjana Zukić Branka Stojiljković Maja Čolović Milica Pavlović Sonja |
spellingShingle |
Spasovski Vesna Tosić Natasa Kostić Tatjana Zukić Branka Stojiljković Maja Čolović Milica Pavlović Sonja The role of FasR/FasL system in pathogenesis of myeloprolyferative neoplasms Archives of Biological Sciences Myeloproliferative neoplasms FasR/FasL JAK2 V617F mutation |
author_facet |
Spasovski Vesna Tosić Natasa Kostić Tatjana Zukić Branka Stojiljković Maja Čolović Milica Pavlović Sonja |
author_sort |
Spasovski Vesna |
title |
The role of FasR/FasL system in pathogenesis of myeloprolyferative neoplasms |
title_short |
The role of FasR/FasL system in pathogenesis of myeloprolyferative neoplasms |
title_full |
The role of FasR/FasL system in pathogenesis of myeloprolyferative neoplasms |
title_fullStr |
The role of FasR/FasL system in pathogenesis of myeloprolyferative neoplasms |
title_full_unstemmed |
The role of FasR/FasL system in pathogenesis of myeloprolyferative neoplasms |
title_sort |
role of fasr/fasl system in pathogenesis of myeloprolyferative neoplasms |
publisher |
University of Belgrade, University of Novi Sad |
series |
Archives of Biological Sciences |
issn |
0354-4664 |
publishDate |
2010-01-01 |
description |
Myeloproliferative neoplasms (MPN) are hematological malignancies characterized by uncontrolled cell proliferation and impaired apoptosis. The FasR/FasL system is involved in the control of apoptosis in different cell types. Here we have investigated the role of FasR/FasL in the pathogenesis of MPNs. We compared FasR/FasL expression between MPN patients (24) and healthy individuals using the real-time PCR assay. We found an increase of FasR expression in MPN patients. No difference was detected in FasL expression. Mutation V617F in the JAK2 gene, a hallmark of MPN, was detected in 13/24 patients. We found that neither FasR nor FasL expression were related to the presence of JAK2 V617F mutation. |
topic |
Myeloproliferative neoplasms FasR/FasL JAK2 V617F mutation |
url |
http://www.doiserbia.nb.rs/img/doi/0354-4664/2010/0354-46641002223S.pdf |
work_keys_str_mv |
AT spasovskivesna theroleoffasrfaslsysteminpathogenesisofmyeloprolyferativeneoplasms AT tosicnatasa theroleoffasrfaslsysteminpathogenesisofmyeloprolyferativeneoplasms AT kostictatjana theroleoffasrfaslsysteminpathogenesisofmyeloprolyferativeneoplasms AT zukicbranka theroleoffasrfaslsysteminpathogenesisofmyeloprolyferativeneoplasms AT stojiljkovicmaja theroleoffasrfaslsysteminpathogenesisofmyeloprolyferativeneoplasms AT colovicmilica theroleoffasrfaslsysteminpathogenesisofmyeloprolyferativeneoplasms AT pavlovicsonja theroleoffasrfaslsysteminpathogenesisofmyeloprolyferativeneoplasms AT spasovskivesna roleoffasrfaslsysteminpathogenesisofmyeloprolyferativeneoplasms AT tosicnatasa roleoffasrfaslsysteminpathogenesisofmyeloprolyferativeneoplasms AT kostictatjana roleoffasrfaslsysteminpathogenesisofmyeloprolyferativeneoplasms AT zukicbranka roleoffasrfaslsysteminpathogenesisofmyeloprolyferativeneoplasms AT stojiljkovicmaja roleoffasrfaslsysteminpathogenesisofmyeloprolyferativeneoplasms AT colovicmilica roleoffasrfaslsysteminpathogenesisofmyeloprolyferativeneoplasms AT pavlovicsonja roleoffasrfaslsysteminpathogenesisofmyeloprolyferativeneoplasms |
_version_ |
1725636858165067776 |